K2 PRINCIPAL FUND, L.P. - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 71 filers reported holding NOVELION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$632,000
+19.2%
89,900
+82.2%
0.04%
-4.5%
Q1 2017$530,000
-76.7%
49,350
-81.7%
0.04%
-79.4%
Q4 2016$2,270,000269,5360.21%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 1,800,000$1,404,0002.63%
Stonepine Capital Management, LLC 491,096$383,0000.26%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 918,342$716,0000.05%
KNOTT DAVID M 109,135$85,0000.04%
EdgePoint Investment Group Inc. 2,831,555$2,209,0000.02%
Yakira Capital Management, Inc. 36,428$28,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$36,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 85,409$66,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 37,717$29,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders